Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings

Shek Man Chim(The University of Western Australia), Harikiran Nistala(Icahn School of Medicine at Mount Sinai), Alan R. Shuldiner(University of Maryland, Baltimore), John Dronzek(Regeneron (United States)), Jonas Bovijn(Regeneron (United States)), Luca Lotta(Regeneron (United States)), Cristopher V. Van Hout(Regeneron (United States)), Adam E. Locke(James S. McDonnell Foundation), Anthony Marcketta(Regeneron (United States)), Susannah Brydges(Regeneron (United States)), Kristen E. Howell(Texas A&M University), Tanima De(Regeneron (United States)), Arunachalam Vinayagam(Regeneron (United States)), Katia Karalis(Regeneron (United States)), Manuel A. R. Ferreira(Broad Institute), David J. Carey(Geisinger Medical Center), Olle Melander, Michelle G. LeBlanc(Toronto General Hospital), Weizhen Wu(Xiamen University), Bin Ye(Regeneron (United States)), Alexander Li(Regeneron (United States)), Aris N. Economides(Regeneron (United States)), Lyndon J. Mitnaul(Regeneron (United States)), Niek Verweij(Netherlands Heart Institute)
eLife
December 13, 2024
Cited by 3


Related Papers